These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23738973)

  • 1. Current treatment options for hyperprolactinemia.
    Faje A; Nachtigall L
    Expert Opin Pharmacother; 2013 Aug; 14(12):1611-25. PubMed ID: 23738973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia: etiology, diagnosis, and management.
    Mah PM; Webster J
    Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
    Conner P; Fried G
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):249-62. PubMed ID: 9539269
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperprolactinemia.
    Biller BM
    Int J Fertil Womens Med; 1999; 44(2):74-7. PubMed ID: 10338264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia after menopause: Diagnosis and management.
    Auriemma RS; Pirchio R; Pivonello R; Colao A
    Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin-secreting tumors: what's new?
    Molitch ME
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S29-35. PubMed ID: 17004854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia and infertility.
    Shibli-Rahhal A; Schlechte J
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):837-46. PubMed ID: 22108283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperprolactinemia: causes, diagnosis, and treatment].
    Karasek M; Pawlikowski M; Lewiński A
    Endokrynol Pol; 2006; 57(6):656-62. PubMed ID: 17253440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of not treating hyperprolactinemia.
    Sanfilippo JS
    J Reprod Med; 1999 Dec; 44(12 Suppl):1111-5. PubMed ID: 10649820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperprolactinemia].
    Oesterle M; Galeazzi RL
    Praxis (Bern 1994); 1995 Jun; 84(25-26):778-83. PubMed ID: 7597365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and reproductive medicine.
    Davis JR
    Curr Opin Obstet Gynecol; 2004 Aug; 16(4):331-7. PubMed ID: 15232488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperprolactinemia in the postmenopause: versions and contraversions].
    Leshchenko OY
    Ter Arkh; 2021 Oct; 93(10):1234-1239. PubMed ID: 36286827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management.
    Pekić S; Medic Stojanoska M; Popovic V
    Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
    López JM; Oestreicher E
    Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.